Skip to content
Medical Health Aged Care

Final day of GP25 to provide a glimpse into the future of general practice care

Royal Australian College of GPs 2 mins read

The third day of the nation’s premier annual GP conference GP25 features prominent leaders and health experts sharing their insights on a range of matters at the forefront of general practice care. 

Speakers at the conference today include Royal Australian College of GPs (RACGP) Senior Medical Educator and Inala Indigenous Health Service worker, Dr Justin Coleman, discussing what matters most in rural and remote general practice care. The last day of GP25 will also feature an international panel discussing lessons for the future of general practice from around the globe. 

RACGP President Dr Michael Wright said day three of GP25 will zero in on vital areas of general practice research and environmental sustainability. 

“General practice research is critical for growing the evidence base about the skills and value of general practices providing the highest standard of care,” he said. 

“Today will feature a ‘rapid fire’ session on innovation, leadership and research in general practice. Another session will delve into the latest developments on preventive care, including Dr Rebecca Moore discussing the loneliness epidemic impacting many patients, and the role of GPs in reducing dementia risk. Dr Tracey Purnell will also talk about how GPs can best help patients managing acne. 

“There will be a panel session featuring Dr Kim Loo, Dr Catherine Pendrey and Dr Nicole Sleeman examining healthcare’s net zero transition and how best to achieve this. The College has spoken out on the fact that climate change is the biggest current threat to the future of the Australian healthcare system, and we’re committed to helping our members make general practice care as environmentally sustainable as possible.” 

Dr Wright said the final day of GP25 will also have a strong focus on mental health care. 

“The latest RACGP Health of the Nation report revealed 71% of GPs nominated mental health as a top reason for patient presentations, up 10% since the survey began in 2017,” he said.  

“The last day of GP25 will see several speakers, including Professor Mark Morgan and Associate Professor Caroline Johnson, taking a close look at antidepressant medication and deprescribing in general practice.  

“This is an issue that is front of mind for all GPs, particularly when you consider that around one in seven Australians take antidepressants. The withdrawal effects patients experience when they discontinue antidepressants can lead to very serious health impacts, and it’s important for us to explore all avenues for making this transition as easy as possible. 

“Every life matters and securing the future of general practice care not only relieves pressure on our entire healthcare system but also ensures that all people can lead the healthier lives.” 

~ENDS   

    

RACGP spokespeople are available for interviews: 03 8699 0992 / [email protected] 

  

 


About us:

About the RACGP  

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians. Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here 


Contact details:

Media team: 03 8699 0992 / [email protected]   

Follow us on Twitter: @RACGP and Facebook.  

More from this category

  • Medical Health Aged Care
  • 02/03/2026
  • 18:11
Takeda Pharmaceutical Company Limited

Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera

Rusfertide Demonstrated Significant Improvements in Hematocrit Control, Phlebotomy Reduction and Patient Reported Outcomes for Patients with Polycythemia Vera in a Pivotal StudySubmission Primarily Based on Phase 3 VERIFY Study, in Which Rusfertide Plus Standard of Care More Than Doubled Clinical Response Rates, as Well as Four-Year Efficacy and Safety Data from Phase 2 REVIVE/THRIVE StudiesPrescription Drug User Fee Act (PDUFA) Target Action Date is in the Third Quarter of this Calendar Year OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif.--BUSINESS WIRE-- Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) today announced that the U.S. Food and Drug Administration (FDA) accepted…

  • Medical Health Aged Care
  • 02/03/2026
  • 13:04
Alexion, AstraZeneca Rare Disease

Ultomiris® now available on the PBS for Australians living with generalised myasthenia gravis

Alexion, AstraZeneca Rare Disease’s Ultomiris® (ravulizumab rch) has been listed on the Pharmaceutical Benefits Scheme (PBS) for adults with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive (Ab+). The Minister for Health and Ageing, The Hon Mark Butler MP, made the announcement at today’s World Rare Disease Day event at Parliament House. Ultomiris is now available on the PBS for people with acute, severe gMG at high risk of rapid deterioration; for short term disease control as other treatments take effect; and for people not responding, intolerant or contraindicated to other therapies.[1],[2] gMG is a rare, debilitating,…

  • Contains:
  • Medical Health Aged Care
  • 02/03/2026
  • 09:00
Monash University

Monash University set to host the 18th Asian Conference on Pharmacoepidemiology

The Centre for Medicine Use and Safety (CMUS) at the Monash Institute of Pharmaceutical Sciences (MIPS) has been successful in the bid to host the 2026 Asian Conference on Pharmacoepidemiology (ACPE). This flagship Asian event of International Society of Pharmacoepidemiology (ISPE) will be held at Monash Parkville Campus from 30 October to 1 November 2026. The conference will bring together more than 300 researchers, global leaders, clinicians and policymakers from across the Asia-Pacific. The event will boost global collaboration in pharmacoepidemiology and related disciplines including pharmacovigilance, health economics and data sciences, and will involve high-quality educational sessions, and keynote lectures.…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.